Major depression raises risks of advanced and severe complications from diabetes, according to a prospective study. These complications include kidney failure or blindness, the result of small vessel damage, as well as major vessel problems leading to myocardial infarction (MI) or stroke.…
Read More »Soft Drink Consumption Increases Risk of Pancreatic Cancer
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report….
Read More »Study Finds the Cause of Blindness from Diabetes
A Michigan State University scientist has finally discovered how high blood sugar levels can cause blindness….
Read More »US Health-Risk Surveillance Results
Results from January 2007 to December 2007 from the Behavioral Risk Surveillance System (BRFSS), an ongoing telephone survey of US adults on health-risk behaviors and the use of preventative healthcare services related to the leading causes of death and disability in the United States, were reported last week….
Read More »Novo reps to spotlight weight loss for Victoza launch
by Ben Comer, writer, Medical Media and Marketing Sales forces for Novo Nordisk’s Victoza (c) will emphasize the injectable’s weight loss properties when it launches next month. Speaking between sales force training workshops, Martin Jernigan, associate VP, Victoza Launch, said the Type 2 diabetes drug is “really about getting A1C …
Read More »miCoach Pacer
miCoach Pacer This product, straight from the CES exhibit in Las Vegas, is the perfect companion for you or your patients’ training workouts. This three part system has a Pacer that interacts with a stride sensor and heart rate monitor. Press it at any time to hear real-time information on …
Read More »SLIMDATA USB
SLIM DATA USB This new product unveiled at the recent CES show in Las Vegas is a must have for any medical professional who carries data on a flash drive. This credit card size flash drive which you can carry in your wallet can hold 4 GB of information and …
Read More »New GLP-1 Medication Lowers A1c Six Months after Treatment Stopped
Transition Therapeutics announces results of a Phase 2 study of TT-223 (GLP-1 Cpd + Gastrin) in Type 2 diabetes patients. The results show that beta-cells can possibly be generated and/or restored. After a 10 week trial the drug was stopped and 6 months later, the A1c had dropped by 1.13 points.
Read More »What You Eat after Exercise Shapes You
The benefits of exercise can be greatly affected by the food we eat after it….
Read More »Low-Carb Diet Reduces Blood Pressure
Researchers have found a low-carbohydrate diet helps people lose weight as effectively as a popular weight loss drug, and trumps the drug at lowering blood pressure….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.